News and Press Releases
Expert Speaker Line-Up Revealed for Industry-Leading RBQM Event
CluePoints Supports Launch of RBQMLive 2024 as Premier Event Sponsor 4 September 2024 -- Pennsylvania, US -- CluePoints, the premier sponsor of RBQMLive and provider of Risk-Based Quality Management (RBQM) and...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 4, 2024
Plexium Selects Xavo as their Sample Management Lab Operations Platform
24 July 2024 -- Massachusetts, US -- Xavo, a leading provider of innovative software solutions for life sciences R&D, proudly announces Plexium as its latest esteemed client. “We are thrilled...
Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: July 24, 2024
CARBOGEN AMCIS Announces Two Successful FDA Inspections at its Manufacturing Sites in Neuland and Aarau, Switzerland
23 July 2024 -- Bubendorf, Switzerland -- Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of...
Category: BioManufacturing, Other, Pharmaceutical
Posted: July 23, 2024
Certa Therapeutics Receives EU Orphan Designation for FT011, a GPR68 Inhibitor Being Developed as an Anti-Fibrotic Treatment for Systemic Sclerosis
22 July 2024 -- Melbourne, Australia -- Certa Therapeutics, a biotechnology company developing innovative precision therapies for patients with inflammatory and fibrotic diseases, today announces that the European Medicines Agency...
Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: July 22, 2024
Pistoia Alliance Research Finds 77% of Researchers Not Using In Vitro Alternatives to Animal Testing, as it Launches Non-Animal Models Community
Alliance calls on experts to join its new collaborative community, seeking to overcome regulatory and data challenges preventing the replacement and reduction of animal testing 11 July 2024 -- Boston,...
Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: July 11, 2024
CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations
Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024 17 June 2024 -- Pennsylvania, US -- CluePoints, provider...
Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: June 17, 2024
CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT
CluePoints is a cloud-based software platform for Risk-Based Quality Management (RBQM) and data quality oversight in clinical trials, designed to enable safer and more efficient processes and improving data integrity...
Category: Biotechnology, Clinical Trials
Posted: June 12, 2024
CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’
CluePoints extends its use of AI/ML and continues to find smarter ways to manage clinical trials 11 June 2024 -- Pennsylvania, US -- CluePoints, provider of leading statistical and AI-driven...
Category: Clinical Trials, Other, Pharmaceutical
Posted: June 11, 2024
FDA and CluePoints Sign New 3 Year Cooperative Research and Development Agreement to Assess Data Quality using Statistical Modelling and Machine Learning
FDA extends its use of CluePoints to include AI/ML within an automated system to assess data quality in multicenter clinical trials 5 June 2024 -- Pennsylvania, US -- CluePoints, providers...
Category: Biotechnology, Pharmaceutical
Posted: June 5, 2024
Scope of Industry Risk-Based Quality Management (RBQM) Adoption Revealed
CluePoints, the Tufts Center for the Study of Drug Development and PwC publish Comprehensive Assessment of RBQM Adoption in Clinical Trials 2 April 2024 -- Pennsylvania, US -- A comprehensive...
Category: Other, Pharmaceutical
Posted: April 2, 2024
CluePoints’ Audit Trail Review Project Wins Award for Innovation in the Management of Clinical Data Award
2024 Annual Association of Clinical Data Management (ACDM24) recognises CluePoints’ improved methodology to proactively identify and address data quality. 5 March 2024 -- Pennsylvania, US -- CluePoints, providers of best-in-class statistical...
Category: Clinical Trials
Posted: March 5, 2024
Ellipses’ next generation selective RET inhibitor EP0031/A400 granted Fast Track designation by US Food and Drug Administration
Compound is currently undergoing clinical trials as a potential treatment option for patients with RET altered tumours 5 March 2024 -- London, UK -- Ellipses Pharma, a global drug development...
Category: Drug Discovery
Posted: March 5, 2024
CN Bio wins ‘Most Impactful Industry Collaboration of the Year’ at the OBN Awards 2023 for ongoing research with the FDA
Six-year collaboration recognised at prestigious awards ceremony for its continued success in advancing OOC research to support widespread adoption across the pharmaceutical industry 23 November 2023 -- Cambridge, UK --...
Category: Clinical Trials
Posted: November 23, 2023
CluePoints wins SCRIP Awards for Best Contract Research Organisation (CRO): Specialist Providers
Company wins prestigious accolade for commitment to innovation and education 17 November 2023 -- Pennsylvania, US -- CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management (RBQM) software for...
Category: Clinical Trials
Posted: November 22, 2023
Signum Surgical Completes Clinical Trial for BioHealx
Galway based company compiling data for submission of a De Novo classification request to US FDA Novel surgical option for the treatment of anal fistula, a painful and debilitating colorectal...
Category: Clinical Trials
Posted: September 12, 2023
